Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

J.S. Vermaat; F.L. Gerritse; A.A. van der Veldt; W.M. Roessingh; T.M. Niers; S.F. Oosting; S. Sleijfers; J.M.L. Roodhart; J.H. Beijnen; J.H.M. Schellens; J.A. Gietema; E. Boven; D.J. Richel; J.B. Haanen; E.E. Voest

doi:10.1016/j.eururo.2012.01.020.

Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

J.S. Vermaat
, F.L. Gerritse
, A.A. van der Veldt
, W.M. Roessingh
, T.M. Niers
, S.F. Oosting
, S. Sleijfers
, J.M.L. Roodhart
, J.H. Beijnen
, J.H.M. Schellens
, J.A. Gietema
, E. Boven
, D.J. Richel
, J.B. Haanen
, E.E. Voest

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	685-695
Number of pages	11
Journal	European Urology
Volume	62
Issue number	4
DOIs	https://doi.org/10.1016/j.eururo.2012.01.020.
Publication status	Published - 2012

Access to Document

10.1016/j.eururo.2012.01.020.

Cite this

Vermaat, J. S., Gerritse, F. L., van der Veldt, A. A., Roessingh, W. M., Niers, T. M., Oosting, S. F., Sleijfers, S., Roodhart, J. M. L., Beijnen, J. H., Schellens, J. H. M., Gietema, J. A., Boven, E., Richel, D. J., Haanen, J. B., & Voest, E. E. (2012). Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients. European Urology, 62(4), 685-695. https://doi.org/10.1016/j.eururo.2012.01.020.

@article{c46b36d9b09a45e78463a8517095bbbe,

title = "Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.",

author = "J.S. Vermaat and F.L. Gerritse and \{van der Veldt\}, A.A. and W.M. Roessingh and T.M. Niers and S.F. Oosting and S. Sleijfers and J.M.L. Roodhart and J.H. Beijnen and J.H.M. Schellens and J.A. Gietema and E. Boven and D.J. Richel and J.B. Haanen and E.E. Voest",

year = "2012",

doi = "10.1016/j.eururo.2012.01.020.",

language = "English",

volume = "62",

pages = "685--695",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "4",

}

Vermaat, JS, Gerritse, FL, van der Veldt, AA, Roessingh, WM, Niers, TM, Oosting, SF, Sleijfers, S, Roodhart, JML, Beijnen, JH, Schellens, JHM, Gietema, JA, Boven, E, Richel, DJ, Haanen, JB & Voest, EE 2012, 'Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.', European Urology, vol. 62, no. 4, pp. 685-695. https://doi.org/10.1016/j.eururo.2012.01.020.

TY - JOUR

T1 - Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients.

AU - Vermaat, J.S.

AU - Gerritse, F.L.

AU - van der Veldt, A.A.

AU - Roessingh, W.M.

AU - Niers, T.M.

AU - Oosting, S.F.

AU - Sleijfers, S.

AU - Roodhart, J.M.L.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

AU - Gietema, J.A.

AU - Boven, E.

AU - Richel, D.J.

AU - Haanen, J.B.

AU - Voest, E.E.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.eururo.2012.01.020.

DO - 10.1016/j.eururo.2012.01.020.

M3 - Article

SN - 0302-2838

VL - 62

SP - 685

EP - 695

JO - European Urology

JF - European Urology

IS - 4

ER -